Moderna says its COVID-19 Vaccine 94.5% Effective; No Safety Concerns

November 16, 2020 Admin

TheGlobeandMail – A second vaccine-maker has announced that its COVID-19 vaccine candidate is performing well in a large-scale clinical trial – further evidence that the battle against the global pandemic is entering a new phase.

On Monday, U.S.-based Moderna Inc. said that interim results from a Phase 3 study of its mRNA-1273 vaccine show that the vaccine is 94.5 per cent effective with no significant safety concerns.

It’s the second round of good news in a week for the travel and tourism sectors, which desperately need help and a restoration of public confidence. Last week Pfizer said early tests of its vaccine showed more than 90% efficacy.

Continue Reading



About the Author



Leave a Reply

©Copyrights 2020. All Rights Reserved.

Subscribe to NewsletterStay Connected!

Sign up for the latest travel news delivered to your inbox.

Subscribe to NewsletterStay Connected!

Sign up for the latest travel news delivered to your inbox.

%d bloggers like this: